Search

everythinglearnresearchcommunity

for

Search:↓

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Finasteride lowers prostate cancer risk but may increase high-grade tumors and sexual side effects.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Testosterone therapy increases bone density in older men with low testosterone levels.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

New alopecia treatments aim for better results and fewer side effects.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Finasteride improves heart function and repairs damage after heart attack in mice.

Young men's sexual dysfunction often has physical causes, which can lead to stress and worsen the problem.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Low-glycemic index diets are beneficial for weight loss and satiety, but more research is needed on long-term effects and individualized approaches are recommended.